Pharmacokinetics of rofecoxib in mild to moderate hepatic insufficiency (HI).

被引：0
|
作者：
Schwartz, J
Zhao, P
Gertz, B
Gumbs, C
Ebel, D
Lasseter, K
Porras, A
机构：
[1] Clin Pharmacol Associates, Miami, FL USA
[2] Merck & Co Inc, Rahway, NJ 07065 USA
[3] Merck & Co Inc, W Point, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2000年 / 67卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII90
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [1] Steady-state rofecoxib pharmacokinetics (PK) in moderate hepatic insufficiency patients (HI).
    Schwartz, JI
    Larson, PJ
    Gertz, BJ
    Cote, J
    Lasseter, K
    Porras, AG
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P60 - P60
  • [2] Mild to moderate hepatic insufficiency does not affect pharmacokinetics and pharmacodynamics of tirofiban
    Depré, M
    Lo, MW
    Van Hecken, A
    De Lepeleire, I
    Hand, EL
    Lowry, R
    Connor, JG
    Murphy, MG
    Fevery, J
    De Schepper, PJ
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R458 - R458
  • [3] Pharmacokinetics of rizatriptan in patients with mild-moderate hepatic insufficiency.
    Goldberg, MR
    Lee, Y
    Panebianco, D
    Noveck, RJ
    Brucker, MJ
    McLoughlin, DA
    Olah, TV
    Shadle, CR
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 186 - 186
  • [4] EFFECT OF MODERATE HEPATIC INSUFFICIENCY ON THE PHARMACOKINETICS OF SITAGLIPTIN
    Migoya, Elizabeth M.
    Stevens, Catherine H.
    Bergman, Arthur J.
    Luo, Wen-Lin
    Lasseter, Kenneth C.
    Dilzer, Stacy C.
    Davies, Michael J.
    Wagner, John A.
    Herman, Gary A.
    [J]. JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2009, 16 (01): : E165 - E170
  • [5] Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment
    Schnell, David
    Buschke, Susanne
    Fuchs, Holger
    Gansser, Dietmar
    Goeldner, Rainer-Georg
    Uttenreuther-Fischer, Martina
    Stopfer, Peter
    Wind, Sven
    Petersen-Sylla, Marc
    Halabi, Atef
    Koenen, Ruediger
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) : 267 - 275
  • [6] Effect of Mild or Moderate Hepatic Impairment on the Pharmacokinetics of Ozanimod
    Zhang, Peijin
    Hosein, Fareeda
    Yu, Kyungha
    Walker, Susan
    Syto, Mary
    Tirucherai, Giridhar
    Murthy, Bindu
    Tatosian, Daniel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S843 - S843
  • [7] Influence of mild and moderate hepatic impairment on axitinib pharmacokinetics
    Tortorici, Michael A.
    Toh, Melvin
    Rahavendran, S. V.
    LaBadie, Robert R.
    Alvey, Christine W.
    Marbury, Thomas
    Fuentes, Ernesto
    Green, Matthew
    Ni, Grace
    Hee, Brian
    Pithavala, Yazdi K.
    [J]. INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1370 - 1380
  • [8] EFFECT OF MILD AND MODERATE HEPATIC IMPAIRMENT ON QUIZARTINIB PHARMACOKINETICS
    Zahir, H.
    Lasseter, K.
    Marbury, T.
    Rondon, J.
    Bermudez, Y.
    Gammon, G.
    Kamel, Y. Mostafa
    Said, N.
    Hsu, C.
    Abutarif, M.
    Zheng, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S20 - S20
  • [9] Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment
    David Schnell
    Susanne Buschke
    Holger Fuchs
    Dietmar Gansser
    Rainer-Georg Goeldner
    Martina Uttenreuther-Fischer
    Peter Stopfer
    Sven Wind
    Marc Petersen-Sylla
    Atef Halabi
    Rüdiger Koenen
    [J]. Cancer Chemotherapy and Pharmacology, 2014, 74 : 267 - 275
  • [10] Influence of mild and moderate hepatic impairment on axitinib pharmacokinetics
    Michael A. Tortorici
    Melvin Toh
    S. V. Rahavendran
    Robert R. LaBadie
    Christine W. Alvey
    Thomas Marbury
    Ernesto Fuentes
    Matthew Green
    Grace Ni
    Brian Hee
    Yazdi K. Pithavala
    [J]. Investigational New Drugs, 2011, 29 : 1370 - 1380
12345